Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Allen et al v. Takeda Pharmaceuticals North America Inc et al
Case Number:
6:12-cv-00064
Court:
Nature of Suit:
Judge:
Firms
- Adams & Reese
- Baker Sterchi
- Davidson Meaux
- Lanier Law Firm
- Neblett Beard
- Nelson Mullins
- Sidley Austin
- Taft Stettinius
- Tucker Ellis
- Venable LLP
- Weitz & Luxenberg
Companies
Sectors & Industries:
-
March 07, 2014
Zyprexa Fines Irrelevant In Actos Trial, Eli Lilly Says
Eli Lilly & Co. argued Thursday that the first federal bellwether trial over the bladder cancer risks of diabetes drug Actos should exclude evidence about its fines for marketing the antipsychotic drug Zyprexa, saying it's not relevant to negligent marketing claims over Actos.
-
March 03, 2014
Plaintiffs Accuse Lilly Of Perjury, Seek Actos Trial Win
A former Eli Lilly & Co. employee lied on the witness stand during the first federal bellwether trial over allegations that the diabetes drug Actos causes bladder cancer, plaintiffs said Friday, asking a Louisiana federal court to enter judgment against the company as a penalty.
- ← Previous
- 1
- 2
- Next →